Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
1
20%
Ph phase_2
2
40%
Ph phase_4
1
20%
Ph not_applicable
1
20%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

completed360%
withdrawn120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD

NCT03055247
withdrawnphase_1

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

NCT03612466
completedphase_2

Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)

NCT02703779
completednot_applicable

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

NCT01206075
completedphase_4

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

NCT02056210

Clinical Trials (5)

Showing 5 of 5 trials
NCT03055247Phase 2

Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD

Recruiting
NCT03612466Phase 1

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Withdrawn
NCT02703779Phase 2

Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)

Completed
NCT01206075Not Applicable

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Completed
NCT02056210Phase 4

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5